HDL and Inflammation in Atherosclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-5917|4|1|51-57

ISSN： 1568-0088

Source： Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol.4, Iss.1, 2004-03, pp. : 51-57

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxidative Stress, HDL and Atherosclerosis

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 7, Iss. 3, 2008-01 ,pp. : 158-165

Bentham Science Publishers

Access to resources Recommend Favorite

ATP-Binding Cassette Transporters A1 and G1, HDL Metabolism, Cholesterol Efflux, and Inflammation: Important Targets for the Treatment of Atherosclerosis

By  

Current Drug Targets, Vol. 12, Iss. 5, 2011-05 ,pp. : 647-660

Bentham Science Publishers

Access to resources Recommend Favorite

Reconstituted HDL fails to ERASE atherosclerosis

By  

Inpharma, Vol. 1, Iss. 1581, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Reversing the Paradigm for Atherosclerosis Therapy: The Potential of HDL Therapeutics

By  

Pharmaceutical Innovation, Vol. 11, Iss. 6, 2002-10 ,pp. : 21-24

Adis International

Access to resources Recommend Favorite

Gliclazide, Inflammation and Atherosclerosis

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 7, Iss. 3, 2008-09 ,pp. : 224-230

Bentham Science Publishers

Access to resources Recommend Favorite